Tyrosine kinase inhibitors in sarcoma treatment (Review)-Reference-Cited by-同舟云学术

Tyrosine kinase inhibitors in sarcoma treatment (Review)

Published:2022-04-21 Issue:6 Volume:23 Page:
ISSN:1792-1074
Container-title:Oncology Letters
language:
Short-container-title:Oncol Lett

Author:

Kyriazoglou Anastasios¹,Gkaralea Lydia²,Kotsantis Ioannis¹,Anastasiou Maria¹,Pantazopoulos Anastasios¹,Prevezanou Maria¹,Chatzidakis Ioannis¹,Kavourakis Georgios¹,Economopoulou Panagiota¹,Nixon Ioanna³,Psyrri Amanda¹

Affiliation:

1. Second Propaedeutic Department of Medicine, Attikon University Hospital, 12462 Athens, Greece

2. Second Department of Medical Oncology, Agii Anargiri Cancer Hospital, 14564 Athens, Greece

3. Sarcoma Oncology, Beatson West of Scotland Cancer Centre, Glasgow G12 0YN, UK

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Reference92 articles.

1. The epidemiology of sarcoma;Burningham;Clin Sarcoma Res,2012

2. Descriptive epidemiology of sarcomas in Europe: Report from the RARECARE project;Stiller;Eur J Cancer,2013

3. Soft Tissue and Bone Tumours;World Health Organization (WHO),2020

4. Burden and centralized treatment in Europe of rare tumors: Results of RARECAREnet-a population-based study;Gatta;Lancet Oncol,2017

5. The epidemiology of osteosarcoma;Ottaviani;Cancer Treat Res,2009

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatments and prognostic factors for bone and soft tissue sarcoma in non-urban areas in Japan;International Journal of Clinical Oncology;2023-12-28

2. Establishment and functional testing of a novel ex vivo extraskeletal osteosarcoma cell model (USZ20-ESOS1);Human Cell;2023-11-11

3. Functional Profiling of Soft Tissue Sarcoma Using Mechanistic Models;International Journal of Molecular Sciences;2023-09-29

4. A Scoping Review on Tyrosine Kinase Inhibitors in Cats: Current Evidence and Future Directions;Animals;2023-09-29

5. Real‐world experience of tyrosine kinase inhibitors in children, adolescents and adults with relapsed or refractory bone tumours: A Canadian Sarcoma Research and Clinical Collaboration (CanSaRCC) study;Cancer Medicine;2023-09